Literature DB >> 18807170

Alteration of DBP levels in CSF of patients with MS by proteomics analysis.

Zhaoyu Qin1, Yanjiang Qin, Shilian Liu.   

Abstract

OBJECTIVE: The diagnosis of multiple sclerosis (MS) is still challenging recently due to the lack of a specific diagnostic test. Proteomics analysis was applied to biomarkers discovery and their pathways study.
METHODS: First, the proteins of CSF from MS patients and control group were analyzed individually with 2D-DIGE technology (two-dimensional difference gel electrophoresis). Then, protein spots were found out with DeCyder6.0 software which showed different expression levels in the gel images between the two groups. The information regarding these proteins was collected based on MALDI-TOF/MS and related database searches. Lastly, interaction between these proteins was further analyzed by using Metacore software.
RESULTS: There were 13 proteins that showed more than 1.5-fold difference in expression levels between the two groups. Furthermore, the identification made by MALDI-TOF/MS revealed that one of the most significant differential proteins was DBP (vitamin D-binding protein), which decreased in the experimental group. This result was confirmed by ELISA (P < 0.01). Moreover, network between the 13 proteins were partially got, which showed some biological interactions.
CONCLUSION: These results support a correlation between the level of DBP and MS. DBP may be a potential useful biomarker for diagnosis or a medicine target for treatment of MS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18807170     DOI: 10.1007/s10571-008-9312-z

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  16 in total

Review 1.  The telltale scan: APOE epsilon4 in multiple sclerosis.

Authors:  Thomas Masterman; Jan Hillert
Journal:  Lancet Neurol       Date:  2004-06       Impact factor: 44.182

Review 2.  The association between apolipoprotein E and multiple sclerosis.

Authors:  M Pinholt; J L Frederiksen; M Christiansen
Journal:  Eur J Neurol       Date:  2006-06       Impact factor: 6.089

3.  Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush.

Authors:  L B Siconolfi; N W Seeds
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

4.  Immunohistochemical study of vascular injury in acute multiple sclerosis.

Authors:  A J Wakefield; L J More; J Difford; J E McLaughlin
Journal:  J Clin Pathol       Date:  1994-02       Impact factor: 3.411

5.  Apo E in multiple sclerosis and optic neuritis: the apo E-epsilon4 allele is associated with progression of multiple sclerosis.

Authors:  M Pinholt; J L Frederiksen; P S Andersen; M Christiansen
Journal:  Mult Scler       Date:  2005-10       Impact factor: 6.312

6.  Proteomic analysis of multiple sclerosis cerebrospinal fluid.

Authors:  B N Hammack; K Y C Fung; S W Hunsucker; M W Duncan; M P Burgoon; G P Owens; D H Gilden
Journal:  Mult Scler       Date:  2004-06       Impact factor: 6.312

Review 7.  Vitamin D as an immune modulator in multiple sclerosis, a review.

Authors:  Joost Smolders; Jan Damoiseaux; Paul Menheere; Raymond Hupperts
Journal:  J Neuroimmunol       Date:  2008-01-04       Impact factor: 3.478

8.  Coagulation status and biochemical and inflammatory markers in multiple sclerosis.

Authors:  Fehime B Aksungar; Aynur E Topkaya; Zeynep Yildiz; Sevki Sahin; Ulku Turk
Journal:  J Clin Neurosci       Date:  2008-02-06       Impact factor: 1.961

Review 9.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

Authors:  Chris H Polman; Stephen C Reingold; Gilles Edan; Massimo Filippi; Hans-Peter Hartung; Ludwig Kappos; Fred D Lublin; Luanne M Metz; Henry F McFarland; Paul W O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Brian G Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  15 in total

Review 1.  Multiple sclerosis, vitamin D, and HLA-DRB1*15.

Authors:  Lahiru Handunnetthi; Sreeram V Ramagopalan; George C Ebers
Journal:  Neurology       Date:  2010-06-08       Impact factor: 9.910

Review 2.  The emerging role of vitamin D binding protein in multiple sclerosis.

Authors:  Giulio Disanto; Sreeram V Ramagopalan; Andrea E Para; Lahiru Handunnetthi
Journal:  J Neurol       Date:  2010-11-02       Impact factor: 4.849

Review 3.  Multiple sclerosis and vitamin D: a review and recommendations.

Authors:  Andrew J Solomon; Ruth H Whitham
Journal:  Curr Neurol Neurosci Rep       Date:  2010-09       Impact factor: 5.081

4.  Vitamin D-binding protein interacts with Aβ and suppresses Aβ-mediated pathology.

Authors:  M Moon; H Song; H J Hong; D W Nam; M-Y Cha; M S Oh; J Yu; H Ryu; I Mook-Jung
Journal:  Cell Death Differ       Date:  2012-12-21       Impact factor: 15.828

5.  Novel approaches to detect serum biomarkers for clinical response to interferon-beta treatment in multiple sclerosis.

Authors:  Kaushal S Gandhi; Fiona C McKay; Eve Diefenbach; Ben Crossett; Stephen D Schibeci; Robert N Heard; Graeme J Stewart; David R Booth; Jonathan W Arthur
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

6.  Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis.

Authors:  Marcel P Stoop; Vaibhav Singh; Lennard J Dekker; Mark K Titulaer; Christoph Stingl; Peter C Burgers; Peter A E Sillevis Smitt; Rogier Q Hintzen; Theo M Luider
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

7.  Distribution of vitamin D binding protein expressing neurons in the rat hypothalamus.

Authors:  Gustav F Jirikowski; Ulrike W Kaunzner; Ulrike W Kauntzer; Abeer El Emmam Dief; Jack D Caldwell
Journal:  Histochem Cell Biol       Date:  2008-11-26       Impact factor: 4.304

8.  Proteome analysis of biomarkers in the cerebrospinal fluid of neuromyelitis optica patients.

Authors:  Shumei Bai; Shilian Liu; Xuxiao Guo; Zhaoyu Qin; Banqin Wang; Xiaohong Li; Yanjiang Qin; Yi-Hsin Liu
Journal:  Mol Vis       Date:  2009-08-19       Impact factor: 2.367

9.  Proteomic analysis of the cerebrospinal fluid of patients with restless legs syndrome/Willis-Ekbom disease.

Authors:  Stephanie M Patton; Yong Won Cho; Thomas W Clardy; Richard P Allen; Christopher J Earley; James R Connor
Journal:  Fluids Barriers CNS       Date:  2013-06-07

10.  Searching for Novel Candidate Biomarkers of RLS in Blood by Proteomic Analysis.

Authors:  Stefania Mondello; Firas H Kobeissy; Yehia Mechref; Jingfu Zhao; Samer El Hayek; Kazem Zibara; Monica Moresco; Giuseppe Plazzi; Filomena I I Cosentino; Raffaele Ferri
Journal:  Nat Sci Sleep       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.